These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hypertrophic gingivitis of drug origin (a review of the literature)]. Petrikas AZh; Kysakova SI Stomatologiia (Mosk); 1993; 72(3):76-8. PubMed ID: 8236316 [No Abstract] [Full Text] [Related]
3. [Gingival hypertrophy due to cyclosporine. A review of the literature]. Vescovi P; Savi A; Oppici A; Gennari PU Minerva Stomatol; 1996 Nov; 45(11):523-32. PubMed ID: 9026698 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of periodontitis associated with cyclosporin-induced severe gingival hyperplasia with regular mechanical plaque removal in a patient with renal transplantation (Case report)]. Keglevich T; Windisch P; Gera I Fogorv Sz; 2002 Feb; 95(1):15-20. PubMed ID: 11924223 [TBL] [Abstract][Full Text] [Related]
6. [Diseases of the oral mucosa. Gingival hypertrophy]. Ben Slama L Rev Stomatol Chir Maxillofac; 2004 Sep; 105(4):235-6. PubMed ID: 15510077 [No Abstract] [Full Text] [Related]
7. Immunoexpression of angiogenesis and proliferation markers in patients treated with cyclosporin A. Afonso M; Perrotti V; Rapani M; Iaculli F; Piccirilli M; Onuma T; Shibli JA; De Oliveira Bello V; Sposto MR; Artese L Minerva Stomatol; 2014 Mar; 63(3):59-67. PubMed ID: 24632797 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of inducible and endothelial forms of nitric oxide synthase in cyclosporin A-induced gingival overgrowth. Gürkan A; Emingil G; Oktem G; Selvi N; Afacan B; Tunç Ilgenli ; Töz H; Atilla G J Periodontol; 2009 Oct; 80(10):1638-47. PubMed ID: 19792854 [TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of cyclosporine induced gingival overgrowth]. Vescovi P; Meleti M; Manfredi M; Bonanini M Minerva Stomatol; 2003 May; 52(5):219-29. PubMed ID: 12874541 [TBL] [Abstract][Full Text] [Related]
10. [Perivascular hyalin substance and calcinosis of the gingiva after cyclosporin A therapy--a new finding]. Sharaf MN; Hofstädter F Pathologe; 1992 Apr; 13(2):117-20. PubMed ID: 1376475 [No Abstract] [Full Text] [Related]
11. [Gingival hypertrophy due to cyclosporine. A clinico-statistical study in 82 patients]. Vescovi P; Savi A; Macaluso GM; Gennari PU Minerva Stomatol; 1997 Apr; 46(4):155-64. PubMed ID: 9221317 [TBL] [Abstract][Full Text] [Related]
12. [Verapamil-induced gingivitis hypertrophica: a clinical case]. Borgia MC; De Paola G; Calpicchio A G Ital Cardiol; 1992 Jan; 22(1):33-5. PubMed ID: 1624067 [No Abstract] [Full Text] [Related]
16. [Hypertrophic gingivitis caused by cyclosporin A. 30 months' clinical experience in the use of cyclosporin A in patients undergoing cadaver kidney transplantation, with special attention to the proven side effects at the gingival level]. Turco G; Ferrari Parabita S; Sacco M; Re G Minerva Stomatol; 1988 Dec; 37(12):1043-50. PubMed ID: 3071732 [No Abstract] [Full Text] [Related]
17. [Risk factors conditioning the incidence and severity of cyclosporine A-induced gingival overgrowth and methods of prevention]. Bartoli F; Castronovo G; Stabile A Minerva Stomatol; 2004 Apr; 53(4):165-70. PubMed ID: 15107773 [TBL] [Abstract][Full Text] [Related]
18. Regulation of type I plasminogen activator inhibitor in human gingival fibroblasts with cyclosporine A. Ho YC; Lin HJ; Tsai CH; Chang YC Oral Dis; 2010 May; 16(4):396-401. PubMed ID: 20233320 [TBL] [Abstract][Full Text] [Related]
19. Factors affecting cyclosporine-induced gingival overgrowth in pediatric renal transplant recipients. Karpinia KA; Matt M; Fennell RS; Hefti AF Pediatr Dent; 1996; 18(7):450-5. PubMed ID: 8970207 [TBL] [Abstract][Full Text] [Related]